Skip to main content
FinSpry Logo
FinSpry
NKTR logo
NKTR
(NASDAQ)
Nektar Therapeutics
$69.36-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Nektar Therapeutics (NKTR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Nektar Therapeutics stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(11 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$154.33
↑ 122.51% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest NKTR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Julian Harrison
BTIG
BuyReiterates
$178.00
Arthur He CFA
HC Wainwright
BuyReiterates
$185.00
Samantha Semenkow
Citi
BuyMaintains
$75.95 → $151.00
Martin Fan
Wedbush
HoldMaintains
$95.00 → $80.00
Arthur He CFA
HC Wainwright
BuyMaintains
$185.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$105.00 → $192.00
Julian Harrison
BTIG
BuyMaintains
$178.00
Marc Frahm
TD Cowen
BuyReiterates
-
Jay Olson
Oppenheimer
BuyMaintains
$140.00
Andy Hsieh
William Blair
BuyReiterates
-
Julian Harrison
BTIG
BuyMaintains
$178.00

Frequently Asked Questions

What is the analyst consensus rating for NKTR?

The analyst consensus rating for NKTR is "Buy" based on 8 analyst recommendations.

What is the average price target for NKTR?

The average 12-month price target for NKTR is $154.33, representing an upside of 122.5% from the current price of $69.36.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.